n/a
Article Publish Status: FREE
Abstract Title:

Effect of Turmacin supplementation on joint discomfort and functional outcome among healthy participants - A randomized placebo-controlled trial.

Abstract Source:

Complement Ther Med. 2020 Sep ;53:102522. Epub 2020 Jul 22. PMID: 33066856

Abstract Author(s):

Jeffrey Pradeep Raj, Shreeraam Venkatachalam, Pranathi Racha, Sreejith Bhaskaran, Rajkumar S Amaravati

Article Affiliation:

Jeffrey Pradeep Raj

Abstract:

OBJECTIVE: Curcuma longa has been widely used in Ayurveda for its medicinal properties and Turmacin was developed from C. longa as a standardized extract containing turmerosaccharides. In this clinical trial, the effect of Turmacin on knee joint discomfort in healthy adults subjected to strenuous physical activity was evaluated.

DESIGN: Double-blind, triple-arm, parallel-group, randomized placebo-controlled trial.

SETTING: Healthy participants from an urban tertiary care teaching hospital.

INTERVENTION: Healthy participants were randomized in 1:1:1 ratio to receive either Turmacin 0.5 g/1 g or placebo once daily for 84 days. The participants were subjected to 10-minute strenuous exercise.

OUTCOME MEASURES: Time to initial pain, final pain score on a visual analogue scale, range of movement (ROM) of knee and the force of contractions of muscles around the knee joint.

RESULTS: A total of n = 90 participants were recruited. The mean final pain scores were significantly lower in the Turmacin 1 g and Turmacin 0.5 g when compared with the placebo from day-7 and day-5 onwards respectively. The survival analysis consistently showed a decreased hazard for early onset of pain in boththe Turmacin groups. On day-84, the difference in mean ROM between Turmacin 0.5 g and placebo was 4.79 degrees (p = 0.008) and that for Turmacin 1 g and placebo was 2.34 degrees (p = 0.306). The difference in muscle force for isokinetic contractions of the quadriceps at angular velocities of 120 and 180 was significant between Turmacin 0.5 g and placebo (p = 0.002 and p = 0.005 respectively) while that for Turmacin 1 g&Turmacin 0.5 g (p = 0.206 and p = 0.414 respectively) and Turmacin 1 g&Placebo (p = 0.046 and p = 0.037) were not significant. However, in the within group analysis participants in Turmacin 1 g group had better preserved muscle functions than Turmacin 0.5 g group at angular velocities of 120 and 180 when compared with placebo.

CONCLUSION: Turmacin (0.5 g and 1 g) was efficacious when compared to placebo in increasing the pain threshold and knee ROM in healthy participants with minor adverse events.

Study Type : Human Study
Additional Links
Therapeutic Actions : Exercise : CK(4855) : AC(921)
Pharmacological Actions : Analgesics : CK(3498) : AC(943)

Print Options


Key Research Topics

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.